NCT01195116

Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: University of Rochester · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.

Detailed description

Inclusion Criteria: Patients with a clinical diagnosis of IC scheduled for cystoscopy and hydrodistension for both diagnostic and therapeutic indications. Data collected will include: I. Postoperative Outcomes i. Pain Reported (Visual Analogue Scale) ii. Post-operative opiate use iii. Time in PACU iv. Time until discharge v. Adverse Events (i.e. nausea/vomiting, nursing intervention) II. Intermediate-term Outcomes (4-6 weeks) i. Interstitial Cystitis Symptom \& Problem Index ii. Revised McGill Pain Score

Conditions

• Interstitial Cystitis

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	1 mcg/kg/hour
DRUG	Normal Saline	1mcg/kg/hr

Timeline

• Start date: 2010-05-01
• Primary completion: 2012-04-01
• Completion: 2012-04-01
• First posted: 2010-09-03
• Last updated: 2015-04-15
• Results posted: 2015-03-24

Locations

1 site across 1 country: United States